Other papers submitted by: Mr Mitsuhiro Ishida

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Mr Mitsuhiro Ishida

Papers published by Mr Mitsuhiro Ishida:

Original Research

Highly-accessed

Efficacy And Safety Of Controlled-Release Oxycodone For The Management Of Moderate-To-Severe Chronic Non-Cancer Pain In Japanese Patients: Results From An Open-Label Study

Kawamata M, Iseki M, Kawakami M, Yabuki S, Sasaki T, Ishida M, Nishiyori A, Hida H, Kikuchi S

Journal of Pain Research 2019, 12:3423-3436

Published Date: 23 December 2019

Original Research

Highly-accessed

Plain language summary

Efficacy and safety of controlled-release oxycodone for the management of moderate-to-severe chronic low back pain in Japan: results of an enriched enrollment randomized withdrawal study followed by an open-label extension study

Kawamata M, Iseki M, Kawakami M, Yabuki S, Sasaki T, Ishida M, Nishiyori A, Hida H, Kikuchi S

Journal of Pain Research 2019, 12:363-375

Published Date: 17 January 2019

Original Research

Highly-accessed

Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study

Itoh N, Tsuji T, Ishida M, Ochiai T, Konno S, Uchio Y

Journal of Pain Research 2018, 11:2603-2616

Published Date: 26 October 2018

Original Research

Highly-accessed

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin

Enomoto H, Yasuda H, Nishiyori A, Fujikoshi S, Furukawa M, Ishida M, Takahashi M, Tsuji T, Yoshikawa A, Alev L

Journal of Pain Research 2018, 11:1857-1868

Published Date: 13 September 2018

Original Research

Noteworthy comment: This paper is noteworthy in that it suggests that duloxetine represents a potentially important non-opioid therapy for knee osteoarthritis. This is of particular importance given physicians' struggles with treating osteoarthritic conditions while maintaining patient safety.

Highly-accessed

Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study

Uchio Y, Enomoto H, Ishida M, Tsuji T, Ochiai T, Konno S

Journal of Pain Research 2018, 11:1391-1403

Published Date: 31 July 2018

Original Research

Highly-accessed

Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study

Tsuji T, Itoh N, Ishida M, Ochiai T, Konno S

Journal of Pain Research 2017, 10:2157-2168

Published Date: 4 September 2017

Original Research

Highly-accessed

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials

Alev L, Fujikoshi S, Yoshikawa A, Enomoto H, Ishida M, Tsuji T, Ogawa K, Konno S

Journal of Pain Research 2017, 10:1723-1731

Published Date: 24 July 2017